Clinical chemistry最新文献

筛选
英文 中文
Lipoprotein(a) in Cardiovascular Disease: Integrating Epidemiology, Clinical Guidelines, Molar Measurement, and Emerging Therapies. 心血管疾病中的脂蛋白(a):整合流行病学、临床指南、摩尔测量和新兴疗法。
IF 8.3 2区 医学
Clinical chemistry Pub Date : 2026-11-13 DOI: 10.1093/clinchem/hvag154
Peter E Thomas, Signe Vedel-Krogh, Florian Kronenberg, Børge G Nordestgaard
{"title":"Lipoprotein(a) in Cardiovascular Disease: Integrating Epidemiology, Clinical Guidelines, Molar Measurement, and Emerging Therapies.","authors":"Peter E Thomas, Signe Vedel-Krogh, Florian Kronenberg, Børge G Nordestgaard","doi":"10.1093/clinchem/hvag154","DOIUrl":"https://doi.org/10.1093/clinchem/hvag154","url":null,"abstract":"<p><strong>Background: </strong>Lipoprotein(a) [Lp(a)] is a causal risk factor for atherosclerotic cardiovascular disease (ASCVD = myocardial infarction, ischemic stroke, peripheral artery disease) and aortic valve stenosis. Plasma concentrations of Lp(a) are >90% genetically determined. Multiple drugs in development reduce lipoprotein(a) by 80% to 98%. While the recently announced topline results, the phase 3 Lp(a)HORIZON trial of pelacarsen did not meet its primary cardiovascular endpoint despite lowering Lp(a), and 3 other cardiovascular outcomes trials remain ongoing. Lipoprotein(a) testing is currently increasing rapidly in many countries.</p><p><strong>Content: </strong>Most guidelines on dyslipidemia and prevention of cardiovascular disease worldwide now advise that Lp(a) should be measured once in all adults, ideally jointly with the first lipid profile ordered. If previous lipid profiles were taken, then Lp(a) should be included in the next lipid profile. Lipoprotein(a) should ideally be measured in nmol/L, and repeat measurements are relevant if drugs are given to lower Lp(a) concentrations, initially at suspected acute coronary syndrome or stroke and again after 1 month, and sometimes in women after menopause. Measuring Lp(a) levels alongside a standard lipid profile provides a more comprehensive initial assessment of a patient's overall cardiovascular risk. Clinical chemistry laboratories that measure lipid profiles should therefore also offer Lp(a) testing. This is easily done as Lp(a) assays can be run on most major clinical chemistry platforms. High Lp(a) is >105 nmol/L (>50 mg/dL).</p><p><strong>Summary: </strong>As use of Lp(a) testing is increasing rapidly worldwide, more clinical chemistry laboratories will likely offer this test locally. Measuring Lp(a) levels alongside a standard lipid profile provides a more comprehensive initial lipid assessment of a patient's cardiovascular risk.</p>","PeriodicalId":10690,"journal":{"name":"Clinical chemistry","volume":" ","pages":""},"PeriodicalIF":8.3,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149402809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From Paper to Pixels: The Final Print Issue of Clinical Chemistry. 从纸到像素:临床化学的最终印刷问题。
IF 8.3 2区 医学
Clinical chemistry Pub Date : 2026-11-13 DOI: 10.1093/clinchem/hvag159
Jason Y Park, Linnea M Baudhuin, Eric S Kilpatrick
{"title":"From Paper to Pixels: The Final Print Issue of Clinical Chemistry.","authors":"Jason Y Park, Linnea M Baudhuin, Eric S Kilpatrick","doi":"10.1093/clinchem/hvag159","DOIUrl":"https://doi.org/10.1093/clinchem/hvag159","url":null,"abstract":"","PeriodicalId":10690,"journal":{"name":"Clinical chemistry","volume":" ","pages":""},"PeriodicalIF":8.3,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149402808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interpretive Challenges in Electrophoretic and Mass Spectrometric Methods for Monoclonal Gammopathy Detection in Patients with Cold Agglutinin Disease. 冷凝集素病患者单克隆γ病检测的电泳和质谱方法的解释挑战。
IF 8.3 2区 医学
Clinical chemistry Pub Date : 2026-11-04 DOI: 10.1093/clinchem/hvag106
Abdalla M Abdalla, Mohammed N Ibrahim, Nicholas G Paciaroni, Jodi V Mones, Anna E Merrill, Shelby M Hutcherson
{"title":"Interpretive Challenges in Electrophoretic and Mass Spectrometric Methods for Monoclonal Gammopathy Detection in Patients with Cold Agglutinin Disease.","authors":"Abdalla M Abdalla, Mohammed N Ibrahim, Nicholas G Paciaroni, Jodi V Mones, Anna E Merrill, Shelby M Hutcherson","doi":"10.1093/clinchem/hvag106","DOIUrl":"10.1093/clinchem/hvag106","url":null,"abstract":"","PeriodicalId":10690,"journal":{"name":"Clinical chemistry","volume":" ","pages":"1201-1203"},"PeriodicalIF":8.3,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148788678","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Highly Accurate Sequencing Methods for Low-Frequency Variant Detection. 低频变异检测的高精度测序方法。
IF 8.3 2区 医学
Clinical chemistry Pub Date : 2026-11-04 DOI: 10.1093/clinchem/hvag074
Farzaneh Darbeheshti, Azeet Narayan, Hayet Radia Zeggar, Viktor A Adalsteinsson, G Mike Makrigiorgos
{"title":"Highly Accurate Sequencing Methods for Low-Frequency Variant Detection.","authors":"Farzaneh Darbeheshti, Azeet Narayan, Hayet Radia Zeggar, Viktor A Adalsteinsson, G Mike Makrigiorgos","doi":"10.1093/clinchem/hvag074","DOIUrl":"10.1093/clinchem/hvag074","url":null,"abstract":"<p><strong>Background: </strong>Next-generation sequencing (NGS), also known as massively parallel sequencing, has become an essential tool across many areas of the life sciences, yet its application to low-frequency variant detection remains constrained by intrinsic error rates and the high cost of ultra-deep sequencing. To overcome these limitations, a range of technologies has been developed at both the library preparation and sequencing strategy levels to improve accuracy and boost sequencing efficiency, complemented by increasingly sophisticated computational pipelines for reliable mutation calling. Sequencing errors arise from multiple sources, including DNA damage, end-repair-associated misincorporations, PCR-derived errors, and base-calling inaccuracies.</p><p><strong>Content: </strong>Broadly, current highly accurate approaches fall into 2 conceptual categories: single-strand-consensus methods, which generate consensus from repeated observations of the same strand, and duplex-consensus methods, which require concordant evidence from both complementary strands of the original DNA molecule. This review summarizes the principles underlying these error correction strategies and highlights the methodological innovations that reduce errors at each step of the work flow.</p><p><strong>Summary: </strong>Highly accurate sequencing approaches have substantially improved the detection of low-frequency variants by reducing technical artifacts and enhancing signal-to-noise ratios.</p>","PeriodicalId":10690,"journal":{"name":"Clinical chemistry","volume":" ","pages":"1116-1131"},"PeriodicalIF":8.3,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148618721","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetic Investigation of X-Linked Defects with Optimized Targeted Long-Read Sequencing. 基于优化靶向长读序列的x连锁缺陷遗传研究。
IF 8.3 2区 医学
Clinical chemistry Pub Date : 2026-11-04 DOI: 10.1093/clinchem/hvag088
Jia Zheng, Keying Li, Jin Han, Chi Chun Chan, Huilin Wang, Jasmine Yan Tung Law, Lin Chen, Fan Jiang, Rui Zhang, Hailei Liang, Xiaofang Chen, Mengmeng Shi, Matthew Hoi Kin Chau, Ye Cao, Yvonne K Kwok, Yuanfang Zhu, Tak Yeung Leung, Kwong Wai Choy, Zirui Dong
{"title":"Genetic Investigation of X-Linked Defects with Optimized Targeted Long-Read Sequencing.","authors":"Jia Zheng, Keying Li, Jin Han, Chi Chun Chan, Huilin Wang, Jasmine Yan Tung Law, Lin Chen, Fan Jiang, Rui Zhang, Hailei Liang, Xiaofang Chen, Mengmeng Shi, Matthew Hoi Kin Chau, Ye Cao, Yvonne K Kwok, Yuanfang Zhu, Tak Yeung Leung, Kwong Wai Choy, Zirui Dong","doi":"10.1093/clinchem/hvag088","DOIUrl":"10.1093/clinchem/hvag088","url":null,"abstract":"<p><strong>Background: </strong>X-linked genetic diseases affect males and females through different inheritance patterns influenced by sex, where differential methylation caused by X-chromosome inactivation can present with a range of asymptomatic, mild, and severe symptoms in females. Targeted long-read sequencing (LRS) through adaptive sampling (AS) shows robust performance in characterizing genomic composition and methylation status within the X chromosome, but it is not optimal for nonhigh-molecular-weight (non-HMW) DNA. Herein, we optimized a targeted LRS for non-HMW DNA and validated its diagnostic utility in families with X-linked genomic variants reported by routine methods.</p><p><strong>Methods: </strong>Twenty families with X-linked genetic defects reported by previous chromosomal microarray analysis and/or low-pass genome sequencing were recruited and underwent optimized targeted LRS. Genomic variants were detected and classified along with haplotype analysis for assessing allele-specific methylation changes.</p><p><strong>Results: </strong>The AS-based protocol was optimized for DNA fragmentation with size selection, library construction, and sequencing, and demonstrated a minimum 15-fold enrichment of targets against nontargets compared with the standard AS-based protocol showing 8.1-fold enrichment. In addition, our optimized LRS detected all of the X-linked variants reported previously and revealed additional findings in 7/20 families (35%). This led to variant reclassification in 3/20 cases (15%) achieved through breakpoint resolution for structural variants and determination of gene methylation status.</p><p><strong>Conclusions: </strong>Our study demonstrated an AS-based protocol optimized for non-HMW DNAs that enabled the comprehensive characterization of genomic and methylation changes, highlighting its robust performance in the genomic evaluation of X-linked genetic defects with promising broader application to other disease states.</p>","PeriodicalId":10690,"journal":{"name":"Clinical chemistry","volume":" ","pages":"1145-1160"},"PeriodicalIF":8.3,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148807849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ramifications of Biological Variability on Tests for Primary Aldosteronism Screening. 生物变异对原发性醛固酮增多症筛查试验的影响。
IF 8.3 2区 医学
Clinical chemistry Pub Date : 2026-11-04 DOI: 10.1093/clinchem/hvag104
Brian G Keevil
{"title":"Ramifications of Biological Variability on Tests for Primary Aldosteronism Screening.","authors":"Brian G Keevil","doi":"10.1093/clinchem/hvag104","DOIUrl":"10.1093/clinchem/hvag104","url":null,"abstract":"","PeriodicalId":10690,"journal":{"name":"Clinical chemistry","volume":" ","pages":"1105-1106"},"PeriodicalIF":8.3,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148807945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rethinking Academic Journal Evaluation: The Dongbi Index. 学术期刊评价的再思考:东笔指数。
IF 8.3 2区 医学
Clinical chemistry Pub Date : 2026-11-04 DOI: 10.1093/clinchem/hvag113
Jingcai Wang
{"title":"Rethinking Academic Journal Evaluation: The Dongbi Index.","authors":"Jingcai Wang","doi":"10.1093/clinchem/hvag113","DOIUrl":"https://doi.org/10.1093/clinchem/hvag113","url":null,"abstract":"","PeriodicalId":10690,"journal":{"name":"Clinical chemistry","volume":"72 11","pages":"1204-1206"},"PeriodicalIF":8.3,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unveiling the Mystery: A Cryptic Case Study of a Hyperphosphatemic Patient with Puzzling Clinical Presentations. 揭开谜底:一个临床表现令人费解的高磷血症患者的神秘病例研究。
IF 8.3 2区 医学
Clinical chemistry Pub Date : 2026-11-04 DOI: 10.1093/clinchem/hvag093
Mehdi Mirzazadeh, Nadia Dehghan, Thomas G Morris
{"title":"Unveiling the Mystery: A Cryptic Case Study of a Hyperphosphatemic Patient with Puzzling Clinical Presentations.","authors":"Mehdi Mirzazadeh, Nadia Dehghan, Thomas G Morris","doi":"10.1093/clinchem/hvag093","DOIUrl":"https://doi.org/10.1093/clinchem/hvag093","url":null,"abstract":"","PeriodicalId":10690,"journal":{"name":"Clinical chemistry","volume":"72 11","pages":"1110-1113"},"PeriodicalIF":8.3,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Commentary on Unveiling the Mystery: A Cryptic Case Study of a Hyperphosphatemic Patient with Puzzling Clinical Presentations. 揭秘:一个临床表现令人费解的高磷血症患者的神秘病例研究。
IF 8.3 2区 医学
Clinical chemistry Pub Date : 2026-11-04 DOI: 10.1093/clinchem/hvag126
Ravinder J Singh
{"title":"Commentary on Unveiling the Mystery: A Cryptic Case Study of a Hyperphosphatemic Patient with Puzzling Clinical Presentations.","authors":"Ravinder J Singh","doi":"10.1093/clinchem/hvag126","DOIUrl":"https://doi.org/10.1093/clinchem/hvag126","url":null,"abstract":"","PeriodicalId":10690,"journal":{"name":"Clinical chemistry","volume":"72 11","pages":"1114"},"PeriodicalIF":8.3,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blood Phosphorylated Tau for the Diagnosis of Alzheimer Disease. 血液磷酸化Tau蛋白对阿尔茨海默病的诊断。
IF 8.3 2区 医学
Clinical chemistry Pub Date : 2026-11-04 DOI: 10.1093/clinchem/hvag048
Alexis S Dadelahi, Melissa M Budelier
{"title":"Blood Phosphorylated Tau for the Diagnosis of Alzheimer Disease.","authors":"Alexis S Dadelahi, Melissa M Budelier","doi":"10.1093/clinchem/hvag048","DOIUrl":"10.1093/clinchem/hvag048","url":null,"abstract":"","PeriodicalId":10690,"journal":{"name":"Clinical chemistry","volume":" ","pages":"1107-1109"},"PeriodicalIF":8.3,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148027679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书